SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-055214
Filing Date
2012-08-07
Accepted
2012-08-07 16:02:22
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-14695_110q.htm 10-Q 953442
2 EX-31.1 a12-14695_1ex31d1.htm EX-31.1 11803
3 EX-31.2 a12-14695_1ex31d2.htm EX-31.2 11749
4 EX-32.1 a12-14695_1ex32d1.htm EX-32.1 6278
5 EX-32.2 a12-14695_1ex32d2.htm EX-32.2 6287
  Complete submission text file 0001104659-12-055214.txt   7896962

Data Files

Seq Description Document Type Size
6 EX-101.INS irwd-20120630.xml EX-101.INS 884119
7 EX-101.SCH irwd-20120630.xsd EX-101.SCH 98040
8 EX-101.CAL irwd-20120630_cal.xml EX-101.CAL 40495
9 EX-101.LAB irwd-20120630_lab.xml EX-101.LAB 1447724
10 EX-101.PRE irwd-20120630_pre.xml EX-101.PRE 715250
11 EX-101.DEF irwd-20120630_def.xml EX-101.DEF 520465
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 121013240
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences